- Diebold Nixdorf Inc (NYSE:DBD) reported a first-quarter FY21 sales decline of 12.1% year-on-year to $829.8 million, missing the consensus of $925.12 million.
- Revenue from Eurasia Banking decreased 15.2% to $277.9 million, Americas Banking fell 8.6% to $284.8 million, and Retail declined 12.3% to $267.1 million.
- The gross profit declined 32.2% Y/Y to $185.3 million, with the margin shrinking 660 basis points to 22.3%.
- Adjusted operating loss for the quarter was $(7.3) million.
- The company held $266.8 million in cash and equivalents as of March 31, 2022.
- Adjusted EBITDA fell 90.6% Y/Y to $9.4 million.
- Adjusted EPS loss of $(1.61) missed the analyst consensus of $(0.20).
- "We expect to see significant cost savings of more than $150 million over the next 12 to 18 months and a return to our original financial growth, profitability, and free cash flow targets by 2024," said CEO Octavio Marquez.
- Outlook: Diebold Nixdorf has cut FY22 sales guidance to $3.7 billion - $3.9 billion from $4.0 billion - $4.2 billion, versus the consensus of $4.04 billion.
- The company expects FY22 adjusted EBITDA of $320 million - $350 million (prior view $440 million - $460 million).
- Price Action: DBD shares are trading lower by 30.4% at $2.66 on the last check Tuesday.
Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
What's Going On With Diebold Nixdorf Shares Today
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member?
Sign in here
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member?
Sign in here
Our Picks